Double blinded, randomized, controlled, phase IV intervention trial. Both groups will receive
a quadratus lumborum Block (QL), using ropivacaine 3.75 mg/mL in the intervention group, and
sterile sodium chloride in the control group. The aim of study is to investigate the effect
of a QL Block on the perioperative pain during postbariatric abdominoplasty.